3Parisi P,Pacchiarotti C,Ferretti A,et al.Gastroesophageal reflux disease vs. Panayiotopoulos syndrome: an underestimated misdiagnosis in pediatric age?[J].Epilepsy Behav,2014,41:6-10.
4L o pez-Alonso M,Moya MJ,Cabo JA,et al.Twenty-four-hour esophageal impedanee-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux[J].Pediatrics,2006,118(2):e299-308.
5MeLeay SC,Green B,Treem W,et al.Population pharmaeokineties of rabeprazole and dosing recommendations for the treatment of gastroesophageal reflux disease in children aged 1-11 years[J].Clin Phannaeokinet. 2014,53(10):943-957.
6Thyssen A,Solanki B,Treem W.Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmaeokinetie of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension[J].Clin Ther,2012, 34(7): 1636-1645.
